Can flaxseed supplementation alleviate blood pressure in patients with metabolic diseases? Evaluating the strength of evidence using a meta-analysis and GRADE approach.
- 2025-06-12
- Journal of diabetes and metabolic disorders 24(2)
- Vali Musazadeh
- Niloofar Hamidi
- Mahsa Mahmoudinezhad
- Ali Jafari
- Farzad Shidfar
- PubMed: 40520241
- DOI: 10.1007/s40200-025-01656-y
Study Design
- Type
- Review
- Sample size
- n = 209
- Population
- patients with metabolic diseases
- Methods
- Meta-analysis of 18 trials (comprising 22 treatment arms) with 1,209 participants; random-effects model for calculating weighted mean differences
Objective
Many clinical trials indicate that flaxseed supplementation may exhibit a significant antihypertensive effect, although the findings are inconsistent. This meta-analysis was conducted to provide a more accurate assessment of the impact of flaxseed supplementation on blood pressure in patients with metabolic diseases.Methods
We conducted a comprehensive search of international databases, such as Scopus, PubMed, Web of Science, and Cochrane Central, with data collection continuing until July 2024. We employed a random-effects model for calculating weighted mean differences (WMDs) to ensure robust analysis.Results
Meta-analysis of 18 trials (comprising 22 treatment arms) with 1,209 participants revealed significant reductions in both systolic (WMD: -4.30 mmHg; 95% CI: -6.64 to -1.96, p < 0.001; I2 = 95.2%, p < 0.001) and diastolic blood pressure (WMD = -2.50 mmHg; 95% CI: -3.88, -1.12, p < 0.001; I2 = 95.0%, p < 0.001) following flaxseed supplementation. More significant effects on SBP and DBP were found in trials with an intervention duration of 10-20 weeks, whole flaxseed, subjects with BMI 25-30 kg/m2, and in patients with hypertension.Conclusion
Flaxseed products have been shown to lower both systolic and diastolic blood pressure levels significantly. Together with traditional medicine, flaxseed may be an effective supplement for hypertension treatment.Supplementary information
The online version contains supplementary material available at 10.1007/s40200-025-01656-y.Research Insights
Meta-analysis of 18 trials ... revealed significant reductions in both systolic ... and diastolic blood pressure (WMD = -2.50 mmHg; 95% CI: -3.88, -1.12, p < 0.001)
- Effect
- Beneficial
- Effect size
- Small
Meta-analysis of 18 trials ... revealed significant reductions in both systolic (WMD: -4.30 mmHg; 95% CI: -6.64 to -1.96, p < 0.001)
- Effect
- Beneficial
- Effect size
- Moderate